The coevolved relationship between Helicobacter pylori and human

被引:0
作者
Luo J. [1 ]
Jin F. [2 ]
机构
[1] Institute of Teacher Education and Psychology, Sichuan Normal University, Chengdu
[2] Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, Beijing
来源
Kexue Tongbao/Chinese Science Bulletin | 2018年 / 63卷 / 08期
关键词
Gastrointestinal microbiome; Helicobacter pylori; Host-flora coevolution; Human health;
D O I
10.1360/N972017-01134
中图分类号
学科分类号
摘要
Helicobacter pylori (H. pylori) is a known pathogen of human stomach which is linked to gastric adenocarcinoma, and antibiotic therapy is commonly used for H. pylori eradication. However, accumilating data have formed enough testimony to convey that H. pylori may have coevolved with human host as symbiotic flora rather than pathogenic bacteria. Firstly, a majority of infected individuals are asymptomatic; only a small fraction of infected individuals develop H. pylori-associated diseases, such as peptic ulcers and, more rarely, gastric adenocarcinomas. Secondly, H. pylori has colonization in human stomach for a long time. Genetic evidences have suggested that H. pylori is one of the oldest and most common occupants of the human gastric microbiome, arriving before the migration out of Eastern Africa over 60000 years ago. Thirdly, H. pylori can confer a benefit to human health. Since mutual benefits obliged both partners to adapt themselves in order to establish stable symbiosis, it is therefore possible that the bacterium confers a benefit to its host under some circumstances and is therefore maintained in the human population. It has been suggested that H. pylori can be beneficial for host health in several aspects, including regression in child asthma and other allergic disorders, confering protection against tuberculosis (TB) through induction of antagonistic interferons for the causative agent, Mycobacterium tuberculosis, and playing a role in reducing the risk of esophageal adenocarcinoma (EAC), gastroesophageal reflux disease, stroke, lung cancer, asthma, allergies, and inflammatory bowel disease. We need rethinking the complexity relationship between H. pylori and human, and the impact of this bacterium on human health. Elimination of H. pylori as permanent resident of human microbiome would not be the first option to deal with gastroduodenal diseases, and the long cohabitation in our stomach calls for more deep studies to elucidate microbiota and human health. In this review, we aim to elucidate the secret of H. pylori infection inducing gastric adenocarcinomas. The coevolved relationship between H. pylori and human may help us understanding why a majority of infected individuals are asymptomatic, while a small fraction of infected individuals develop gastric adenocarcinomas. Thus, we elucidate the detail about the long period of H. pylori gastric colonization for 60000 years, and the highly adaptable strategies used by H. pylori to make a lifelong colonization, which has been obtained in the longtime coevolved with human. On basis of these, we discuss the impact of H. pylori on human health, and explore future therapeutic strategies for disease management in light of the longstanding evolutionary history between H. pylori and its human host. We suggest that disrupted coevolution between a pathogen and its human host can induce diseases like gastric adenocarcinoma, and maintaining symbiosis is key for effective detection, management, and disease prevention. © 2018, Science Press. All right reserved.
引用
收藏
页码:701 / 711
页数:10
相关论文
共 86 条
[71]  
Stearns J.C., Lynch M.D.J., Senadheera D.B., Et al., Bacterial biogeography of the human digestive tract, Sci Rep, 1, (2011)
[72]  
Li X.-X., Wong G.L.-H., To K.-F., Et al., Bacterial microbiota profiling in gastritis without Helicobacter pylori infection or non-steroidal anti-inflammatory drug use, PLoS One, 4, (2009)
[73]  
Lofgren J.L., Whary M.T., Ge Z., Et al., Lack of commensal flora in H. pylori-infected INS-GAS mice reduces gastritis and delays intraepithelial neoplasia, Gastroenterology, 140, pp. 210.e4-220.e4, (2011)
[74]  
Delgado S., Cabrera-Rubio R., Mira A., Et al., Microbiological survey of the human gastric ecosystem using culturing and pyrosequencing methods, Microbial Ecol, 65, pp. 763-772, (2013)
[75]  
Biarc J., Nguyen I.S., Pini A., Et al., Carcinogenic properties of proteins with pro-inflammatory activity from Streptococcus infantarius (formerly S. bovis), Carcinogenesis, 25, pp. 1477-1484, (2004)
[76]  
Dicksved J., Lindberg M., Rosenquist M., Et al., Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls, J Med Microbiol, 58, pp. 509-516, (2009)
[77]  
Yang I., Woltemate S., Piazuelo M.B., Et al., Different gastric microbiota compositions in two human populations with high and low gastric cancer risk in Colombia, Sci Rep, 6, (2016)
[78]  
Lind T., Van Zanten S.V., Unge P., Et al., Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: The MACH I study, Helicobacter, 1, pp. 138-144, (1996)
[79]  
Fischbach L., Evans E.L., Meta-analysis: The effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori, Aliment Pharm Therap, 26, pp. 343-357, (2007)
[80]  
Venerito M., Krieger T., Ecker T., Et al., Meta-analysis of bismuth quadruple therapy versus clarithromycin triple therapy for empiric primary treatment of Helicobacter pylori infection, Digestion, 88, pp. 33-45, (2013)